Richard J. Creger

A Phase I Study of Midostaurin and Azacitidine in Relapsed and Elderly AML Patients

Brenda Cooper, Tamila L. Kindwall‐Keller, Michael Craig et al. · Clinical Lymphoma Myeloma & Leukemia · 2015 · 77 citations · Full text

Translational Medicine, Medicine, Elderly Aml Patients +2

High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma.

Hillard M. Lazarus, P. A. Crilley, N. Ciobanu et al. · Journal of Clinical Oncology · 1992 · 74 citations

Lowering the Prophylactic Platelet Transfusion Threshold: a Prospective Analysis

Jeffry B. Lawrence, Roslyn Yomtovían, Terry Hammons et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2001 · 72 citations

Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: Possible implications for treatment related toxicity

Leo I. Gordon, Susan G. Brown, Martin S. Tallman et al. · Free Radical Biology and Medicine · 1995 · 71 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +13

Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile.

Karen K. Fields, Gerald J. Elfenbein, Hillard M. Lazarus et al. · Journal of Clinical Oncology · 1995 · 70 citations